28 Oct 2016

Video of the Week: A second Renaissance for trauma care

Professor Mark Fitzgerald is Director of the National Trauma Research Institute at Monash University and of Alfred Trauma Services. He is an internationally renowned expert in the field. On 12 October 2016, Mark gave Central Clinical School's annual public lecture. He presented on the history and development of trauma care, saying that we were now in a second Renaissance for innovations. See more:

Forthcoming CCS events: 31 Oct-4 Nov 2016

2015 CCS postgraduate symposium
Central Clinical School has regular seminar series and postgraduate presentations. All event notices are maintained on the CCS Events calendar.
CCS staff & students can see details of both public and local events (including professional development courses, trade fairs and Graduate Research Student calendars) and deadlines, at the Intranet's Announcements page. Various departments have their own calendars.

See CCS seminar index:www.med.monash.edu.au/cecs/events/seminars.html.

What's on for 31 Oct-4 Nov 2016

Wed 2/11/2016 11:30 Immunology Seminar: Dr Ashley Mansell, Hudson Institute
15:30 PhD Pre-submission seminar: Mr Man-Kit Sam Lee
Thu 3/11/2016 10:00 CCS Graduate Research Symposium 2016
12:00 Grand Rounds: Pre-surgical functional MRI: Cutting Edge Mind Reading?
Fri 4/11/2016 09:00 ACBD/Monash Health Annual Research Symposium

Forthcoming events

Tue 08/11/2016 11:00 PhD Confirmation Seminar: Dr Yee-May Victoria
Wed 09/11/2016 11:30 PhD Pre-Submission Seminar: Ms Kirsty Wilson
Thu 10/11/2016 12:00 Grand Rounds

Publications for week ending 28 Oct 2016

TXA is beneficial for heart surgery patients.
See feature article on the ATACAS study.
Recent publications for Central Clinical School affiliated authors in the departments of ACBD, AIRmed, Anaesthesia, Immunology, MAPrc, Medicine, Neuroscience, Surgery.  

Anaesthesia and Perioperative Medicine

Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S; ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. N Engl J Med. 2016 Oct 23. [Epub ahead of print] DOI: 10.1056/NEJMoa1606424

26 Oct 2016

Major surgery outcomes improved with TXA

Tranexamic acid (TXA) reduces the risk of
serious bleeding complications by 40%
New research shows the medication TXA could nearly halve the number of people who suffer complications with bleeding following open heart and other major surgery.

Tranexamic acid (TXA) reduces the risk of serious bleeding complications by 40 per cent, resulting in fewer blood transfusions and emergency re-operations, according to a global study which involved 30 hospitals in seven countries. It was led by a team at the Alfred Hospital and Monash University.

Doctors had been concerned about using TXA because of fears that it might increase the risk of heart attack or stroke. But the world-wide study, funded by the Australian and New Zealand College of Anaesthetists (ANZCA) and the NHMRC, found that the drug did not increase thrombosis after open-heart surgery.

Female burns patients fare badly after discharge

Female burns victims have poorer quality
of life than their male counterparts.
Photo: Sunday Night 7 News
by Anne Crawford

Monash University and Alfred Hospital researchers have called for measures to urgently improve the long-term care of female burns patients after a study showed they experienced significantly reduced quality of life compared to men after burn injury.

Gut bacteria may aid anti-cancer treatment

Dr Mutsa Madonda completed his PhD with Prof Magdalena
Plebanski and is now a post doc in her lab.
by Anne Crawford

Monash University researchers are part of an international collaboration that has identified two intestinal bacteria as being potentially important in the effectiveness of anti-cancer medication.

The researchers found that the compound Cyclophosphamide (CTX), used in chemotherapy, relies on Enterococcus hirae and Barnesiella intestinihominis for its efficacy in countering tumours.

Their study, published in the journal Immunity, shows that the two gut bacteria changed the tumour microenvironment, activating T cells and helping the body fight cancer cells. More specifically, they reduced regulatory T cells and stimulated anti-tumour Cytotoxic T lymphocytes (CTL) responses.

Congratulations to NHMRC Fellowship & Development Grant CCS recipients!

Congratulations to all recipients of National Health & Medical Research Council Fellowship funding starting from 2017. Central Clinical School Fellowship (x4) and Development Grant (x1) recipients are:

Dr Stuart Marshall - Health Professional Research Fellowship (part-time). Stuart is in the Department of Anaesthesia and Perioperative Medicine. Almost every member of clinical staff in hospitals now carries a smartphone or tablet. These devices can improve staff performance when life-saving information such as reminders of complex procedures during medical emergencies are delivered in a clear way. This fellowship applies design processes used in other high-risk industries such as in military and nuclear power settings to devise ‘e-aids’ for clinicians to improve outcomes in health emergencies. Stuart can be followed at @hypoxicchicken.

25 Oct 2016

Congratulations to AIRmed's Difficult Asthma Clinic on their Team Award for Leading Innovation

Mr Ron Steiner, A/Prof Mark Hew, Ms Fiona Hore-Lacy,
Dr Naghmeh Radhakrishna, Mr Andrew Way
The Alfred held its Recognising Excellence Awards evening on Thursday 20 October, during Alfred Research Week. The event was MCed by Virginia Trioli from the ABC. Andrew Way, Alfred Health's CEO, presented the Team Award for Leading Innovation to the Difficult Asthma Clinic.

This was one of 12 awards for the night, selected from more than 160 nominations.

Related Posts Plugin for WordPress, Blogger...